Low Impact Covid-19 Alternative Treatment Strategy based on Chiroptera (Bat) Physiology and Inflammatory Reduction

4 Pages Posted: 13 Mar 2020

Date Written: March 9, 2020

Abstract

The current Covid-19 transmission to human physiology has been speculated to commence from Chiroptera (sub-species bat). This paper is an independent initiated response (call for low impact research/clinical study) to determine if the bat species can provide an alternative medicinal based approach to combating the Covid-19 virus proliferation and endemic characteristics using ayurvedic Indian spices that generate a mediated anti-inflammatory human response at the cellular level, thereby inhibiting either viral overload, entry, replication or RNA synthesis. This paper can also serve the basis of extension studies associated with high impact high transmission pathogens like Covid-19.

Keywords: covid-19, coronavirus, alternative remedy

JEL Classification: I1

Suggested Citation

Fernandez, Steve, Low Impact Covid-19 Alternative Treatment Strategy based on Chiroptera (Bat) Physiology and Inflammatory Reduction (March 9, 2020). Available at SSRN: https://ssrn.com/abstract=3551641

Steve Fernandez (Contact Author)

Modus Operandi, Inc. ( email )

London
United Kingdom

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
5
Abstract Views
37
PlumX Metrics